gopubmed logo
 
find other proteinsAll proteins
GoPubMed Proteins lists recent and important papers and reviews for proteins. Page last changed on 29 May 2015.

Epidermal growth factor receptor

EGFR
The protein encoded by this gene is a transmembrane glycoprotein that is a member of the protein kinase superfamily. This protein is a receptor for members of the epidermal growth factor family. EGFR is a cell surface protein that binds to epidermal growth factor. Binding of the protein to a ligand induces receptor dimerization and tyrosine autophosphorylation and leads to cell proliferation. Mutations in this gene are associated with lung cancer. Multiple alternatively spliced transcript variants that encode different protein isoforms have been found for this gene. [provided by RefSeq, Jul 2010] (from NCBI)
Top mentioned proteins: CAN, HAD, V1a, erbB-2, Akt
Papers using EGFR antibodies
Studying lipids involved in the endosomal pathway.
Supplier
Johannes Ludger, In PLoS ONE, 2011
... South San Francisco, CA); EEA1 (Transduction Laboratories); LAMP1 (CD107a; BD Biosciences); EGFR (BD Biosciences); α-tubulin (Sigma- Aldrich) ...
Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer
Supplier
Croce Carlo M. et al., In Nature medicine, 2010
... Targeting of both the c-Met and EGFR pathways results in additive inhibition of lung tumorigenesis in transgenic mice ...
Total internal reflection STED microscopy
Supplier
Bewersdorf Joerg et al., In Biomedical Optics Express, 2010
... A linker encoding the signal sequence of EGFR was inserted into 5′ MCS of pSNAPf vector (New England Biolabs) using the unique NheI ...
Expression profiling of ETS and MMP factors in VEGF-activated endothelial cells: role of MMP-10 in VEGF-induced angiogenesis.
Supplier
Gaetano Carlo, In PLoS ONE, 2009
... Materials: The antibodies of VEGF, PEDF, TNF-α, epidermal growth factor receptor (EGFR) were purchased from Abcam, Cambridge, MA, USA ...
Sequence-Dependent Sorting of Recycling Proteins by Actin-Stabilized Endosomal Microdomains.
Supplier
Caplan Steve H., In PLoS ONE, 2009
... Louis, MO), and mouse anti-EGFR was from Cell signaling technology (Danvers, MA) ...
more suppliers
Papers on EGFR
Maintenance treatment with cetuximab and BAY86-9766 increase antitumor efficacy of irinotecan plus cetuximab in human colorectal cancer xenograft models.
New
Ciardiello et al., Napoli, Italy. In Clin Cancer Res, 27 Jun 2015
EXPERIMENTAL DESIGN: We have investigated in three models of highly EGFR dependent CRC xenografts, the effect of maintenance therapy with different kinase inhibitors alone or in combination with cetuximab, after cytotoxic treatment induction with irinotecan plus cetuximab.
Induction of PD-L1 Expression by the EML4-ALK Oncoprotein and Downstream Signaling Pathways in Non-Small Cell Lung Cancer.
New
Okamoto et al., Kurume, Japan. In Clin Cancer Res, 27 Jun 2015
Furthermore, expression of PD-L1 was down-regulated by inhibitors of the MEK-ERK and PI3K-AKT signaling pathways in NSCLC cells positive for either EML4-ALK or activating mutations of the epidermal growth factor receptor (EGFR).
RasGRP1 opposes proliferative EGFR-SOS1-Ras signals and restricts intestinal epithelial cell growth.
New
Impact
Roose et al., San Francisco, United States. In Nat Cell Biol, 25 Jun 2015
UNASSIGNED: The character of EGFR signals can influence cell fate but mechanistic insights into intestinal EGFR-Ras signalling are limited.
Biomarker-driven diagnosis of diffuse gliomas.
Review
New
Brat et al., Atlanta, United States. In Mol Aspects Med, 21 Jun 2015
Primary GBMs typically lack IDH mutations and demonstrate EGFR, PTEN, TP53, PDGFRA, NF1 and CDKN2A/B alterations and TERT promoter mutations.
Honokiol inhibits the growth of head and neck squamous cell carcinoma by targeting epidermal growth factor receptor.
New
Katiyar et al., Birmingham, United States. In Oncotarget, 19 Jun 2015
Honokiol decreased the expression levels of epidermal growth factor receptor (EGFR), mTOR and their downstream signaling molecules.
Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M.
New
Impact
Oxnard et al., Waltham, United States. In Nat Med, 04 Jun 2015
UNASSIGNED: Here we studied cell-free plasma DNA (cfDNA) collected from subjects with advanced lung cancer whose tumors had developed resistance to the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) AZD9291.
The latest therapeutic strategies after resistance to first generation epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs) in patients with non-small cell lung cancer (NSCLC).
Review
New
Liu et al., Nantong, China. In Ann Transl Med, 31 May 2015
First-generation epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs), gefitinib and erlotinib, produce reliable responses and survival benefits in selected patients with advanced non-small cell lung cancer (NSCLC).
Blood as a Substitute for Tumor Tissue in Detecting EGFR Mutations for Guiding EGFR TKIs Treatment of Nonsmall Cell Lung Cancer: A Systematic Review and Meta-Analysis.
New
Tang et al., Hong Kong, Hong Kong. In Medicine (baltimore), 31 May 2015
UNASSIGNED: Tumor tissues are often absent or insufficient for testing epidermal growth factor receptor (EGFR) mutations to guide EGFR tyrosine kinase inhibitors (TKIs) treatment of patients with nonsmall cell lung cancer (NSCLC).We conducted this systematic review and meta-analysis to assess whether blood can be used as a substitute for tumor tissue in detecting EGFR mutations.MEDLINE, EMBASE, and the Cochrane Library were searched for studies that provided data to estimate the accuracy of blood testing against tissue testing in NSCLC patients and/or those directly compared the efficacy of EGFR TKIs in EGFR mutant and wild-type patients according to sources of specimens.Sensitivity, specificity, and concordance rate were used as measures of the accuracy.
Rociletinib in EGFR-mutated non-small-cell lung cancer.
New
Impact
Camidge et al., Villejuif, France. In N Engl J Med, 30 May 2015
BACKGROUND: Non-small-cell lung cancer (NSCLC) with a mutation in the gene encoding epidermal growth factor receptor (EGFR) is sensitive to approved EGFR inhibitors, but resistance develops, mediated by the T790M EGFR mutation in most cases.
AZD9291 in EGFR inhibitor-resistant non-small-cell lung cancer.
New
Impact
Ranson et al., Taipei, Taiwan. In N Engl J Med, 30 May 2015
BACKGROUND: The EGFR T790M mutation is the most common mechanism of drug resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in patients who have lung cancer with an EGFR mutation (EGFR-mutated lung cancer).
Impact of Specific Epidermal Growth Factor Receptor (EGFR) Mutations and Clinical Characteristics on Outcomes After Treatment With EGFR Tyrosine Kinase Inhibitors Versus Chemotherapy in EGFR-Mutant Lung Cancer: A Meta-Analysis.
New
Impact
Yang et al., Sydney, Australia. In J Clin Oncol, 20 May 2015
PURPOSE: We examined the impact of different epidermal growth factor receptor (EGFR) mutations and clinical characteristics on progression-free survival (PFS) in patients with advanced EGFR-mutated non-small-cell lung cancer treated with EGFR tyrosine kinase inhibitors (TKIs) as first-line therapy.
Soy and Breast Cancer: Focus on Angiogenesis.
Review
New
Mojzis et al., Košice, Slovakia. In Int J Mol Sci, Dec 2014
Genistein was found to inhibit angiogenesis through regulation of multiple pathways, such as regulation of VEGF, MMPs, EGFR expressions and NF-κB, PI3-K/Akt, ERK1/2 signaling pathways, thereby causing strong antiangiogenic effects.
Defining the role of tyrosine kinase inhibitors in early stage non-small cell lung cancer.
Review
New
Zarogoulidis et al., Thessaloníki, Greece. In J Cancer, Dec 2014
Distinct subtypes of NSCLC are driven by a specific genetic alteration, like EGFR, ALK, ROS1 or BRAF mutations, and these genetic alterations are sensitized to the inhibition of specific oncogenic pathways.
Personalized treatment strategies for non-small-cell lung cancer in Chinese patients: the role of crizotinib.
Review
New
Wu et al., Guangzhou, China. In Onco Targets Ther, Dec 2014
Anaplastic lymphoma kinase (ALK) rearrangement is an oncogene targeted with approved drugs second to epidermal growth factor receptor (EGFR) in lung cancer.
The pharmacokinetics and long-term therapeutic effects of gefitinib in patients with lung adenocarcinoma harboring the epidermal growth factor receptor(EGFR)mutation.
GeneRIF
Kudo et al., Japan. In Gan To Kagaku Ryoho, 2012
high concentration of gefitinib is not necessary to achieve long-term therapeutic effects in patients with lung adenocarcinoma harboring the EGFR mutation
Quantitation of the effect of ErbB2 on epidermal growth factor receptor binding and dimerization.
GeneRIF
Pike et al., Saint Louis, United States. In J Biol Chem, 2012
a molecular explanation for the apparent preference of the EGF receptor for dimerizing with ErbB2 and suggest that the phosphorylation of ErbB2 occurs largely in the context of the EGFR/ErbB2 heterodimer
Influence of chemotherapy on EGFR mutation status among patients with non-small-cell lung cancer.
Impact
GeneRIF
Wang et al., Beijing, China. In J Clin Oncol, 2012
Chemotherapy may reduce EGFR mutation frequency in patients with non-small cell lung carcinoma, likely the result of a preferential response of subclones with EGFR mutations in tumors with heterogeneous tumor cell populations.
[Prognostic significance of changes of tumor epidermal growth factor receptor expression after neoadjuvant chemoradiation in patients with rectal adenocarcinoma].
GeneRIF
Petera et al., Hradec Králové, Czech Republic. In Strahlenther Onkol, 2012
An increase of EGFR expression during chemoradiation may be associated with significantly shorter DFS and OS.
Atonal and EGFR signalling orchestrate rok- and Drak-dependent adherens junction remodelling during ommatidia morphogenesis.
GeneRIF
Pichaud et al., London, United Kingdom. In Development, 2012
Atonal and EGFR signalling orchestrate rok- and Drak-dependent adherens junction remodelling during ommatidia morphogenesis.
Veighey et al., Southampton, United Kingdom. In Unknown Journal, 0001
Important secondary outcomes were estimated GFR (eGFR) (using routine clinical assessment), safety, inflammatory cytokine profile and biological mechanisms.
More papers using EGFR antibodies
Emerging roles of Wnts in the adult nervous system.
Supplier
Katoh Masaru, In PLoS ONE, 2009
... Anti phospho-ERK1/2, antiphospho-EGFR (Tyr1068 and Tyr1086), antiphospho-Akt (S473) and total EGFR antibodies were from Cell Signaling Technology Inc (Danvers, MA, ...
Treatment of eccrine porocarcinoma with metastasis to the parotid gland using intensity-modulated radiation therapy: a case report
Supplier
Hoque Mohammad O., In PLoS ONE, 2009
... CA), ER (SP1, prediluted, Ventana Medical Systems, Tucson, AZ), PR (1E2, prediluted, Ventana Medical Systems), EGFR (3C6, prediluted, Ventana Medical Systems), and HER2 (4B5, prediluted, ...
Effect of gefitinib on N-nitrosamine-4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced lung tumorigenesis in A/J mice.
Supplier
Sun Shi-Yong, In PLoS ONE, 2008
Santa Cruz), anti-β-Tubulin and -β-Actin (Sigma-Aldrich); and anti-phospho-EGFR (Y1086, Abcam), and anti-EGFR, -ERK, -Akt ...
Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients
Supplier
Richardson Andrea L et al., In Breast Cancer Research : BCR, 2008
... USA), CK18 (DC10 antibody, Dako) and CK19 (RCK108 antibody, Dako) as well as for EGFR (EGFR pharmDX kit, Dako) and p53 (DO-7 antibody, ...
Randomized, placebo-controlled, phase II study of sequential erlotinib and chemotherapy as first-line treatment for advanced non-small-cell lung cancer
Supplier
Smrdel Uros et al., In Journal of Biomedicine and Biotechnology, 2008
... To detect EGFR gene-activating mutations, we used TheraScreen EGFR29 Mutation Kit (DxS Diagnostics, Qiagen, Manchester, UK) ...
Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy.
Supplier
Carvalho Luzia Helena, In PLoS ONE, 2008
... Antibodies to GAPDH, EGFR, MCP-1, and RANTES were purchased from Santa Cruz Biotechnology, Inc ...
Prediction of BRCA1-association in hereditary non-BRCA1/2 breast carcinomas with array-CGH
Supplier
Domagala Wenancjusz et al., In Virchows Archiv, 2008
... EGFR staining was performed using the EGFR pharmDx kit (Dako) with incubation with proteinase ...
HGF-independent Potentiation of EGFR Action by c-Met
Supplier
Siegfried Jill M. et al., In Oncogene, 2007
... Mouse anti-c-Met, rabbit anti-EGFR, rabbit anti-Y1234/35-Met and anti-rabbit and anti-mouse-HRP linked secondary antibodies were obtained from Cell Signaling (Beverly, MA) ...
Close-to-native ultrastructural preservation by high pressure freezing
Supplier
Bergmann Andreas, In PLoS ONE, 2007
... The following EGFR RNAi transgenic lines were used: ...
Lysine acetylation: codified crosstalk with other posttranslational modifications
Supplier
Sorkin Alexander et al., In The Journal of Cell Biology, 2007
... monoclonal antibody to ubiquitin (P4D1), rabbit polyclonal antibodies to Grb2, Cbl (C-15), Shc (H-108), and EGFR (1005) were purchased from Santa Cruz Biotechnology, Inc ...
Higher constitutive IL15R alpha expression and lower IL-15 response threshold in coeliac disease patients.
Supplier
Holowka David, In PLoS ONE, 2007
... Cruz Biotechnology, Santa Cruz, CA, USA) and mouse anti-alpha tubulin (Sigma-Aldrich, Milan, Italy) and rabbit anti-EGFR (Cell Signaling Celbio, Milan, Italy) antibodies ...
Neuroprotection and stroke: time for a compromise
Supplier
Docagne Fabian et al., In The Journal of Experimental Medicine, 2006
... Rabbit anti–mouse pErk1/2 and pAkt and anti–mouse phosphorylated EGFR antibodies were obtained from Cell Signaling Technology ...
Potential use of an anticancer drug gefinitib, an EGFR inhibitor, on allergic airway inflammation.
Supplier
Munderloh Ulrike Gertrud, In PLoS ONE, 2006
... antibody against phospho-IκBα, IκBα, phospho-IKKα/β, IKKα, IKKβ, phospho-p38, p38, phospho-MKK3/6, MKK3, phospho-Akt, Akt, phospho-EGFR and EGFR were purchased from Cell Signaling (MA, USA) ...
Evidence for functional redundancy of class IA PI3K isoforms in insulin signalling
Supplier
Waugh M G et al., In Cell Death & Disease, 2006
... Anti-EGFR was from Cell Signaling Technologies (Hertfordshire, UK) and ...
Decreased expression of antioxidant enzymes and increased expression of chemokines in COPD lung
Supplier
van Oosterhout Antoon J et al., In Respiratory Research, 2006
... EGFR and phospho-EGFR detected by western blotting using anti-phospho-EGFR (1173 tyrosine residue) and anti-EGFR (Santa Cruz Biotechnology, Santa Cruz, CA) ...
CXCL10 promotes invasion-related properties in human colorectal carcinoma cells
Supplier
Wang J M et al., In British Journal of Cancer, 2006
... against phosphorylated Akt, Akt, phosphorylated p38, p38, phosphorylated Erk, Erk, phosphorylated EGFR (tyrosine 992) and EGFR were from Cell Signaling Technology (Beverly, MA, USA) ...
Effect of the anti-receptor ligand-blocking 225 monoclonal antibody on EGF receptor endocytosis and sorting.
Supplier
Lewin Alfred, In PLoS ONE, 2005
... To prepare the substrate for selection, human EGFR-Fc protein was immobilized to Protein G magnetic beads (New England Biolabs, Ipswich, MA) as follows: ...
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes.
Supplier
Cordes Nils, In PLoS ONE, 2005
... indicated suppliers: Cell Signaling Technologies: phospho-IGF-1R (tyrosine 1131/1135/1136), phospho-Akt (Ser 473), Akt, cleaved PARP, phospho-STAT3, EGFR and Akt1; Santa Cruz Biotechnology: IGF-1R, PTK6, Erk2, tubulin; ...
ErbB2 increases vascular endothelial growth factor protein synthesis via activation of mammalian target of Rapamycin/p70S6K leading to increased angiogenesis and spontaneous metastasis of human breast cancer cells.
Supplier
Blagosklonny Mikhail V., In PLoS ONE, 2005
... were all obtained from Cell Signaling Technology Inc (Danvers, MA) and anti-p-Tyr-EGFR1173 as well as anti-EGFR were from Santa Cruz Biotechnology (Santa Cruz, CA) ...
Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts
Supplier
Chen Hong-Chen et al., In Journal of Biomedical Science, 2004
... Monoclonal anti-EGFR (ab30) was purchased from Abcam.
Human tumor cell growth inhibition by nontoxic anthocyanidins, the pigments in fruits and vegetables
Supplier
Wulf Gerburg M et al., In Breast Cancer Research : BCR, 2004
... Phycoerythrin (PE)-conjugated mouse anti-EGFR antibody (EGFR.1,
Inhibition of radiation-induced EGFR nuclear import by C225 (Cetuximab) suppresses DNA-PK activity
Supplier
Rodemann H Peter et al., In Molecular Cancer, 2004
... The EGFR-inhibitory antibody Erbitux was purchased from Merck KG aA, Germany and ...
Signal transduction for protease-activated receptor-2-triggered prostaglandin E2 formation in human lung epithelial cells
Supplier
Inagaki Chiyoko et al., In Respiratory Research, 2004
... human TGF-β1 was from Peprotech EC (Margravine Rode, London, UK); antibodies against E-cadherin, GAPDH and phospho-EGFR (specific for Tyr1173) were from Santa Cruz Biotechnology, Inc., (Santa Cruz, CA, ...
Luteinising hormone-releasing hormone analogue reverses the cell adhesion profile of EGFR overexpressing DU-145 human prostate carcinoma subline
Supplier
Wells A et al., In British Journal of Cancer, 2004
... Primary antibodies to phospho-EGFR (Cell Signaling, Danvers, MA, USA), ...
Evaluation of biologic end points and pharmacokinetics in patients with metastatic breast cancer after treatment with erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor
Supplier
Press M F et al., In British Journal of Cancer, 2003
... A polyclonal rabbit antibody to the C-terminus epitope of EGFR was obtained from Santa Cruz Biotechnology, Santa Cruz, CA, USA ...
Label-Free Quantitation of Protein Modifications by Pseudo Selected Reaction Monitoring with Internal Reference Peptides
Supplier
Ham Amy-Joan L. et al., In Journal of Proteome Research, 2003
For Western blotting, primary antibodies forphosphotyrosine site 1172, phosphotyrosine site 998 and EGFR were purchased from Cell Signaling Technology (Danvers, MA) ...
Expression of luminal and basal cytokeratins in human breast carcinoma
Supplier
Pogoda Katarzyna et al., In Journal of Neuro-Oncology, 2003
... Immunohistochemistry for cytokeratin 5/6 (Clone D5/16B4, DAKO, dilution scale 1:100), HER1 (EGFR pharm Dx, Clone 2-18C9, DAKO, RTU) and c-KIT (CD117, ...
Age-related changes in VEGF-dependency and angiopoietin-1 induced plasticity of adult blood vessels.
Supplier
Welm Alana L., In PLoS ONE, 2003
... The antibodies against VEGF (human-specific) and EGFR were purchased from Epitomics Inc ...
Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex
Supplier
Hynes Nancy E et al., In Breast cancer research : BCR, 2003
... used in this study: extracellular signal-regulated kinase 1/2 (ERK1/2), p-ERK1/2, total β-catenin, poly(ADP-ribose)polymerase (PARP), EGFR, p-EGFR (tyrosine [Tyr] 845), and p-Tyr-100 (Cell Signaling Technology, Inc., Danvers, MA, ...
Insulin-like growth factor-I inhibits transcriptional responses of transforming growth factor-beta by phosphatidylinositol 3-kinase/Akt-dependent suppression of the activation of Smad3 but not Smad2.
Supplier
Nurminsky Dmitry I., In PLoS ONE, 2002
... (Abcam, ab654), Glut3 (made in Devaskar's lab, UCLA), Glut1 (Abcam, ab15309), IGFR (Cell Signaling, 111A9), EGFR, (Santacruz, sc 03, 1005), Glucose-6-P dehydrogenase (Abcam, ab34436), Protein Kinase C-zeta ...
Can correct protein models be identified?
Supplier
Jensen-Jarolim Erika et al., In Molecular Immunology, 2002
... removed with xylene from sections and immunohistochemistry was performed using the FDA-approved in vitro diagnostic EGFR pharm Dx™ (DAKO, Glostrup, Denmark) and HercepTest ...
CD105 expression is a marker of high metastatic risk and poor outcome in breast carcinomas: correlations between immunohistochemical analysis and long-term follow-up in a series of 929 patients
Supplier
Saxena Sunita et al., In The Indian Journal of Medical Research, 2002
... the biomarkers- AR (Neomarkers; Fremont, CA, 1:50); ER (DAKO; Denmark, 1:50); PR (DAKO; Denmark, 1:50); EGFR (DAKO; Denmark, 1:50) and CD105 ...
Efficient expression system of human recombinant laminin-5.
Supplier
Chakravarti Shukti, In PLoS ONE, 2001
... integrin α6 (GoH3); mouse mAbs to integrin α3 (P1B5) and EGFR (528); rabbit pAbs to EGFR (1005), and integrin ß4 (H101) (Santa Cruz Biotechnology, Inc., Santa Cruz, CA); ...
Nesca, a novel adapter, translocates to the nuclear envelope and regulates neurotrophin-induced neurite outgrowth
Supplier
Meakin Susan O. et al., In The Journal of Cell Biology, 2001
... Other primary antibodies used were EGFR and GFP (Santa Cruz Biotechnology, Inc.), phospho-p44/42 MapK (New ...
The investigation of death from diseases caused by coal-burning type of arsenic poisoning
Supplier
Waalkes Michael P. et al., In Environmental Health Perspectives, 2001
... (sc-1616) and poly-clonal antibodies against cyclin D1 (sc-753), cdk4 (sc-601), and endothelial growth factor receptor (EGFR, sc-03) were obtained from Santa Cruz Biotechnology (Santa Cruz, CA) ...
Atomic model of the papillomavirus capsid.
Supplier
Imperiale Michael, In PLoS Pathogens, 2001
... siRNA cell transfection was performed using Lipofectamine 2000 reagent (Invitrogen), with EGFR siRNA (Cell Signaling) according to manufacturer's recommendations ...
Gleevec (STI571) influences metabolic enzyme activities and glucose carbon flow toward nucleic acid and fatty acid synthesis in myeloid tumor cells
Supplier
Friess Helmut et al., In Molecular Cancer, 2000
... Phospho-PDGFR-beta (tyr857) and p-EGFR (tyr1173) polyclonal antibodies were purchased from Santa Cruz Biotechnology, Inc ...
Gene Expression Omnibus
Supplier
Golub Todd R et al., In Genome Biology, 1998
... EGFR and mouse cKIT antibodies were purchased from Santa Cruz Biotechnology [ ...
Protein tyrosine phosphorylation influences adhesive junction assembly and follicular organization of cultured thyroid epithelial cells
Supplier
Turner T et al., In British Journal of Cancer, 1996
... -catenin, and p120 (Transduction Laboratories, California, USA), phosphorylated MARCKS (Cell Signaling, Massachusetts, USA), phosphorylated EGFR (Cell Signaling, Massachusetts, USA), and EGFR ...
Prevention of radiolysis of monoclonal antibody during labeling
Supplier
van Dongen Guus A. M. S. et al., In European Journal of Nuclear Medicine and Molecular Imaging, 1995
... MAb cetuximab (Erbitux; 2.0 mg/ml) directed against the epidermal growth factor receptor (EGFR) was purchased from Merck (Darmstadt, Germany) [ ...
The stress activated protein kinase pathway mediates cell death following injury induced by cis-platinum, UV irradiation or heat
Supplier
Adler G et al., In British Journal of Cancer, 1995
... , and the EGFR were obtained from Santa Cruz Biotechnology (Santa Cruz, USA) ...
Ligand-induced transformation by a noninternalizing epidermal growth factor receptor
Supplier
Poulsen H S et al., In British Journal of Cancer, 1989
... The antiphospho-EGFR (Tyr1086) antibody was from Biosource (USA).Antibody to tubulin was from Santa Cruz Biotechnology Inc ...
Electroblotting of multiple gels: a simple apparatus without buffer tank for rapid transfer of proteins from polyacrylamide to nitrocellulose
Supplier
Johannes Ludger, In PLoS ONE, 1983
... The following primary antibodies were used: rabbit anti-EGFR antibody (Cell Signaling Technology); rabbit anti-COX IV ...
Nonparametric estimator from incomplete observations.
Supplier
Minna John D., In PLoS ONE, 1957
... Anti-EGFR (SC-03) antibody from Santa Cruz Biotechnology, Inc ...
share on facebooktweetadd +1mail to friends